Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance

Rosy Reynolds, Shazad Mushtaq, Michael K. Allen, Carolyne Horner, Christopher Longshaw, David M. Livermore

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Antimicrobial Chemotherapy
Early online date19 Jan 2022
Publication statusE-pub ahead of print - 19 Jan 2022

Cite this